Delivery Order SPE2DB22D3004-SPE2DB23FPX11

Award Date 4/18/23
Potential Completion Date 4/19/23
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,301.78, is a firm fixed-price delivery order for the supply of TRAMADOL HCL ER 100 MG TABLET 30S, a pain management medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,034.75 Firm Fixed Price Delivery Order is for the supply of TRAMADOL HCL ER 300 MG TABLET 30S, a pain management medication. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,771.82, is for the delivery of TRAMADOL HCL ER 100 MG TABLET 30S, a pain medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,952.89, is for the delivery of 4567060102 - TRAMADOL HCL ER 200 MG TABLET 30S. The contract type is Delivery Order with a Firm Fixed Price pricing mechanism. The ultimate completion date is January 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of TRAMADOL HCL ER 100 MG TABLET 30S to the Defense Logistics Agency (DLA). The $1,741.54 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with a period of performance through December 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999. The award, which has a ceiling value of $1,521.50, is for the supply of TRAMADOL HCL ER 300 MG TABLET 30S, a pharmaceutical product, to support military treatment programs and facilities worldwide. The contract has a firm fixed-price pricing type and a completion date...
This federal contract award, valued at $4,267.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRAMADOL HCL ER 200 MG TABLET 30S, a pain management medication, with a completion date of November 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.62 delivery order is for Tramadol HCL ER 300 mg tablets, a pain management medication. The contract has no set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,002.39 firm fixed-price delivery order is for the supply of TRAMADOL-ACETAMINOPHN 37.5-325 100S tablets. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DX15D3020|SPE2DX24FPYQY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,682.02 firm fixed-price delivery order is for the supply of 4,565,906,036 units of TRAMADOL HCL ER 300 MG TABLET 30S, with a completion date of September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB23FPX11
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,209.53 firm fixed-price delivery order is for the supply of TRAMADOL HCL ER 300 MG TABLET 30S, a specialty pain medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/9/25, 9:52 AM